Dementia

We work closely with the Brain Research Center in the Netherlands, which specialises in high-quality clinical trial execution and scientific publication.

We also have a close partnership and short lines of communication with Amsterdam Neuroscience, with whom we integrate basic, translational, and clinical research into trials.

Dementia Forum UK provides a vital platform for collaboration and innovation in addressing the challenges of dementia.

The European DLB consortium (E-DLB) is a multicenter and global effort concieved by leaders from the contributing centers and leading scientists in different areas of DLB research

Dr Atticus H Hainsworth

Atticus is a neuroscientist and expert in stroke, dementia and vascular cognitive impairment at St Georges, University of London. Atticus leads the Vascular Health theme within DPUK’s Experimental Medicine Incubator.

Prof John Gallacher

Director of DPUK and Professor of Cognitive Health at Oxford University. Renowned for his expertise in brain health and the utilization of big data in medical research, John also holds a visiting professorship at Imperial College London and an honorary professorship at the University of Hong Kong.

SAPHIR phase IIa

24 patients | 7 countries | 120 sites

Multicentre Project to assess the Safety and Tolerability of Treatment in Subjects with early stage Alzheimer’s Disease.

Phase III European

240 patients | 5 countries | 30 sites

Study to assess safety and efficacy in patients with mild cognitive impairment to mild dementia due to Alzheimer’s Disease.

Phase II Netherlands

13 patients | 1 country | 1 site

An EEG study to evaluate synaptic activity in subjects with mild to moderate Alzheimer’s Disease.

Phase II

200 patients | 7 countries | 36 sites

Multi-center study to evaluate the efficacy and safety in patients with mild cognitive impairment due to Alzheimer’s Disease or mild Alzheimer’s Disease.